ALNY vs MMLP · P/E 76, rev $1.29B vs rev $401.3M
Alnylam Pharmaceuticals Inc (ALNY) versus Martin Midstream Partners LP (MMLP) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Martin Midstream Partners LP (MMLP) is a oil & gas midstream company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported MMLP revenue for 2026-06-30 was $401.3M. Net income was -$4.1M. MMLP currently screens at market cap $115.2M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. MMLP currently screens at market cap $115.2M.
Not investment advice. Open the ALNY and MMLP stock pages for the full models.
Not investment advice.